JP2010524928A5 - - Google Patents

Download PDF

Info

Publication number
JP2010524928A5
JP2010524928A5 JP2010504018A JP2010504018A JP2010524928A5 JP 2010524928 A5 JP2010524928 A5 JP 2010524928A5 JP 2010504018 A JP2010504018 A JP 2010504018A JP 2010504018 A JP2010504018 A JP 2010504018A JP 2010524928 A5 JP2010524928 A5 JP 2010524928A5
Authority
JP
Japan
Prior art keywords
igfbp
composition
igf
use according
birth
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010504018A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010524928A (ja
JP5449134B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/SE2008/050441 external-priority patent/WO2008130315A1/en
Publication of JP2010524928A publication Critical patent/JP2010524928A/ja
Publication of JP2010524928A5 publication Critical patent/JP2010524928A5/ja
Application granted granted Critical
Publication of JP5449134B2 publication Critical patent/JP5449134B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010504018A 2007-04-18 2008-04-18 未熟児合併症の治療及び/又は予防の方法と製品 Active JP5449134B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US92396307P 2007-04-18 2007-04-18
US60/923,963 2007-04-18
PCT/SE2008/050441 WO2008130315A1 (en) 2007-04-18 2008-04-18 Method and product for treatment and/or prevention of complications of prematurity

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013189927A Division JP2013249317A (ja) 2007-04-18 2013-09-13 未熟児合併症の治療及び/又は予防の方法と製品

Publications (3)

Publication Number Publication Date
JP2010524928A JP2010524928A (ja) 2010-07-22
JP2010524928A5 true JP2010524928A5 (https=) 2011-05-12
JP5449134B2 JP5449134B2 (ja) 2014-03-19

Family

ID=39875739

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010504018A Active JP5449134B2 (ja) 2007-04-18 2008-04-18 未熟児合併症の治療及び/又は予防の方法と製品
JP2013189927A Pending JP2013249317A (ja) 2007-04-18 2013-09-13 未熟児合併症の治療及び/又は予防の方法と製品

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013189927A Pending JP2013249317A (ja) 2007-04-18 2013-09-13 未熟児合併症の治療及び/又は予防の方法と製品

Country Status (5)

Country Link
US (3) US8518877B2 (https=)
EP (1) EP2148695B1 (https=)
JP (2) JP5449134B2 (https=)
CN (1) CN101969983B (https=)
WO (1) WO2008130315A1 (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2148695B1 (en) * 2007-04-18 2014-10-15 Premacure AB Method and product for treatment and/or prevention of complications of prematurity
JP6284341B2 (ja) 2012-10-24 2018-02-28 国立大学法人東京農工大学 未熟児網膜症の治療又は予防剤、未熟児網膜症の検査方法及び未熟児網膜症の治療又は予防物質のスクリーニング方法
US9510055B2 (en) 2013-01-23 2016-11-29 Sonos, Inc. System and method for a media experience social interface
US20150220498A1 (en) 2014-02-05 2015-08-06 Sonos, Inc. Remote Creation of a Playback Queue for a Future Event
US9679054B2 (en) 2014-03-05 2017-06-13 Sonos, Inc. Webpage media playback
US20150324552A1 (en) 2014-05-12 2015-11-12 Sonos, Inc. Share Restriction for Media Items
US20150356084A1 (en) 2014-06-05 2015-12-10 Sonos, Inc. Social Queue
US9874997B2 (en) 2014-08-08 2018-01-23 Sonos, Inc. Social playback queues
EP3114852A1 (en) 2014-09-24 2017-01-11 Sonos Inc. Social media queue
WO2016049342A1 (en) 2014-09-24 2016-03-31 Sonos, Inc. Social media connection recommendations based on playback information
US9959087B2 (en) 2014-09-24 2018-05-01 Sonos, Inc. Media item context from social media
US10645130B2 (en) 2014-09-24 2020-05-05 Sonos, Inc. Playback updates
US9690540B2 (en) 2014-09-24 2017-06-27 Sonos, Inc. Social media queue
US9860286B2 (en) 2014-09-24 2018-01-02 Sonos, Inc. Associating a captured image with a media item
US9667679B2 (en) 2014-09-24 2017-05-30 Sonos, Inc. Indicating an association between a social-media account and a media playback system
US9723038B2 (en) 2014-09-24 2017-08-01 Sonos, Inc. Social media connection recommendations based on playback information
WO2018093797A1 (en) * 2016-11-15 2018-05-24 The Schepens Eye Research Institute, Inc. Compositions and methods for the treatment of aberrant angiogenesis
EP4663184A3 (en) * 2017-09-11 2026-03-18 Oak Hill Bio Limited Compositions for reducing the incidence of bpd
WO2019099560A1 (en) 2017-11-14 2019-05-23 The Schepens Eye Research Institute, Inc. Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition
CN114126640B (zh) * 2019-05-28 2024-10-29 爱儿安制药有限公司 治疗视网膜病变的组合物和方法
WO2023242442A1 (en) * 2022-06-17 2023-12-21 Oak Hill Bio Limited Method of maturing/differentiating neurons and/or modulating the vagus nerve
WO2023242440A1 (en) * 2022-06-17 2023-12-21 Oak Hill Bio Limited Treament of lungs in infants
EP4598630A1 (en) * 2022-10-04 2025-08-13 Oak Hill Bio Limited Method of treating neonates with igf-1 complex
WO2024160999A1 (en) * 2023-02-03 2024-08-08 Oak Hill Bio Limited Treatment of kidney injury with igf-1 complex
WO2024170612A1 (en) * 2023-02-14 2024-08-22 Oak Hill Bio Limited Treatment of healing dysregulation in gi tissue

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL71991A (en) 1983-06-06 1994-05-30 Genentech Inc Preparation of human FGI and FGE in their processed form through recombinant AND tranology in prokaryotes
US5187151A (en) * 1991-02-12 1993-02-16 Genentech, Inc. Use of binding protein with igf-i as an anabolic growth promoting agent
JPH07508025A (ja) * 1992-05-08 1995-09-07 トーマス・ジェファーソン・ユニバーシティ インスリン様増殖因子(igf−1)類似体
US5563046A (en) 1993-08-02 1996-10-08 Celtrix Pharmaceuticals, Inc. Fusion polypeptides and proteins
US5789547A (en) 1995-06-07 1998-08-04 Celtrix Pharmaceuticals, Inc. Method of producing insulin-like growth factor-I (IGF-I) and insulin-like growth factor binding protein-3 (IGFBP-3) with correct folding and disulfide bonding
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6040292A (en) * 1999-06-04 2000-03-21 Celtrix Pharmaceuticals, Inc. Methods for treating diabetes
DE60143858D1 (de) 2000-11-28 2011-02-24 Premacure Ab Reduzierung DES RISIKOS FÜR KOMPLIKATIONEN BEI FRÜHGEBURTEN
EP1906969A4 (en) * 2005-07-15 2009-07-29 Childrens Medical Center METHOD FOR TREATING AND DIAGNOSIS OF COMPLICATIONS IN AN EARLY BIRTH
EP2148695B1 (en) * 2007-04-18 2014-10-15 Premacure AB Method and product for treatment and/or prevention of complications of prematurity

Similar Documents

Publication Publication Date Title
JP2010524928A5 (https=)
KR101836957B1 (ko) 당뇨병, 저혈당 및 관련 장애를 치료 및 예방하기 위한 인슐린과 크롬을 포함하는 조성물
US9463222B2 (en) Methods for treatment of complications of prematurity comprising administration of IGF-I and IGFBP-3
Kuriyam et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients
JP2006328074A5 (https=)
ES2968043T3 (es) Nuevos derivados de oxintomodulina y composición farmacéutica para el tratamiento de la obesidad que comprende la misma
Sezai et al. Low-dose continuous infusion of human atrial natriuretic peptide during and after cardiac surgery
EP2329848B2 (en) Lixisenatide as add-on therapy to insulin glargine and metformin for treating type 2 diabetes
JP2011500850A5 (https=)
BR112020016613A2 (pt) Composições para o tratamento de doença hepática gordurosa não alcóolica e esteato-hepatite não alcoólica
CN101631558A (zh) 基于艾塞那肽和达拉根的用于治疗糖尿病的药物、其用途和治疗模式
JP2024038042A (ja) 肥満の治療および体重管理のためのglp-1組成物
WO2013059879A1 (en) Compositions and methods for the treatment of fibrosis and fibrotic diseases
Duan et al. Obesity, metabolic syndrome, and sleep disorders
JP2020533344A (ja) 慢性肺疾患を治療するための方法および組成物
EP4445909B1 (en) Pharmaceutical formulation consisting of c-peptide combined with a bisphosphonate in a single form and its use in the treatment of osteosarcopenia
WO2006130769A3 (en) Methods for treatment of growth disorders
US20260069586A1 (en) Methods for reducing weight and preserving or increasing tissue lean mass in patients suffering from cushing's syndrome
WO2026038132A1 (en) Use of gpr119 agonists for the treatment of weight related disorders
WO2026090182A1 (en) Glp-1 receptor agonist and ursolic acid combinations and use thereof for increasing weight loss while improving muscle mass and strength
CN121368489A (zh) 用于治疗代谢障碍的glp-1类似物
AU2009238271B2 (en) Method of treatment of diabetes type 2 comprising add-on therapy to insulin glargine and metformin
WO2026037397A1 (zh) Glp-1类似物的医药用途
Celik et al. Medical therapy of acromegaly in Turkey
Wolden-Hanson Peripheral ghrelin treatment stabilizes body weights of senescent male Brown Norway rats at baseline and after surgery